cannabis indica

Índice completo — página 14 de 77

Estudos 1.301 a 1.400 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2022. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 1.301 a 1.400

  1. 2022

    Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review

    InconclusivoMetanáliseDependência QuímicaDependência — Cannabis
  2. 2022

    Prevalence of Adolescent Cannabis Vaping: A Systematic Review and Meta-analysis of US and Canadian Studies

    DesfavorávelMetanáliseLesão Pulmonar por Vaping (EVALI)
  3. 2022

    Preventive Medication Patterns in Bipolar Disorder and Their Relationship With Comorbid Substance Use Disorders in a Cross-National Observational Study

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — CannabisDependência — Álcool+2
  4. 2022

    Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA

  5. 2022

    Profiling Cannabinoid Contents and Expression Levels of Corresponding Biosynthetic Genes in Commercial Cannabis (Cannabis sativa L.) Cultivars

    InconclusivoEstudo LaboratorialTetraidrocanabinol (THC)Canabigerol (CBG)+9
  6. 2022

    Prospective effects of loneliness on frequency of alcohol and marijuana use

  7. 2022

    Protection of CCl 4-induced hepatic and renal damage by linalool

    FavorávelEstudo em AnimaisInsuficiência HepáticaDoença Renal Crônica
  8. 2022

    Protective actions of vitamin D, anandamide and melatonin during vascular inflammation: Epigenetic mechanisms involved

  9. 2022

    Protective antioxidative and anti-inflammatory actions of β-caryophyllene against sulfasalazine-induced nephrotoxicity in rat

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoNefropatia Induzida por Medicamentos
  10. 2022

    Protective Effects of Cannabidiol on Chemotherapy-Induced Oral Mucositis via the Nrf2/Keap1/ARE Signaling Pathways

    FavorávelEstudo em AnimaisCâncerInflamaçãoDoenças Cardiovasculares (DCV)+7
  11. 2022

    Public interest in ∆ 8-Tetrahydrocannabinol (delta-8-THC) increased in US states that restricted ∆ 9-Tetrahydrocannabinol (delta-9-THC) use

    InconclusivoMetanáliseDelta-8-THC
  12. 2022

    Quantitative electroencephalographic analysis as a potential biomarker of response to treatment with cannabidiol

  13. 2022

    Racial and ethnic differences in alcohol, cannabis, and illicit substance use treatment: a systematic review and narrative synthesis of studies done in the USA

  14. 2022

    Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer

    FavorávelMetanáliseCâncerCâncer — MamaCâncer — Metastático
  15. 2022

    Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol

  16. 2022

    Randomized controlled trial of motivational interviewing for alcohol and cannabis use within a predominantly Hispanic adolescent sample

  17. 2022

    Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review

  18. 2022

    Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis

    DesfavorávelMetanáliseEfeitos Adversos da CannabisAnsiedadeDepressão+3
  19. 2022

    Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and Their Therapeutic Potential

    FavorávelMetanáliseEndocanabinoide (não especificado)
  20. 2022

    Receptor-targeted nanoparticles modulate cannabinoid anticancer activity through delayed cell internalization

    FavorávelEstudo LaboratorialCâncer
  21. 2022

    Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+4
  22. 2022

    Recreational Marijuana Use and Coronary Artery Dissection: A Case Series

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)
  23. 2022

    Regulating for Safety: Cannabidiol Dose in Food: A Review

    DesfavorávelMetanáliseCanabigerol (CBG)Canabinol (CBN)+6
  24. 2022

    Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)InfartoAterosclerose
  25. 2022

    Responsiveness to mHealth Intervention for Cannabis Use in Young Adults Predicts Improved Outcomes

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  26. 2022

    Resting-state EEG, Substance use and Abstinence After Chronic use: A Systematic Review

  27. 2022

    Review of delta-8-tetrahydrocannabinol (Δ8-THC): Comparative pharmacology with Δ9-THC

    InconclusivoMetanáliseTetraidrocanabinol (THC)Delta-8-THC
  28. 2022

    Rewarding effect of ethanol-induced conditioned place preference in mice: Effect of the monoterpenoid linalool

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Álcool
  29. 2022

    Rice Bran Lipidome Identifies Novel Phospholipids, Glycolipids, and Oxylipins with Roles in Lipid Metabolism of Hypercholesterolemic Children

  30. 2022

    RIFM fragrance ingredient safety assessment, β-caryophyllene, CAS Registry Number 87-44-5

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  31. 2022

    Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoAnsiedadeDoenças Cardiovasculares (DCV)DepressãoCanabinoides Sintéticos SR-x+2
  32. 2022

    Risks and Benefits of Cannabis and Cannabinoids in Psychiatry

    InconclusivoMetanálise ClínicaPsicose
  33. 2022

    Road traffic injuries and substance use in Latin America: A systematic review

  34. 2022

    Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents

  35. 2022

    Role of Cannabinoids in Various Diseases: A Review

  36. 2022

    Role of cannabis in inflammatory bowel diseases

  37. 2022

    Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — MamaCanabicromeno (CBC)
  38. 2022

    Role of the cannabinoid CB1 receptor in methamphetamine-induced social and recognition memory impairment

  39. 2022

    Role of the endocannabinoid system in the pathophysiology of endometriosis and therapeutic implications

  40. 2022

    Role of the Endocannabinoid System in the Regulation of Intestinal Homeostasis

  41. 2022

    Role of the major terpenes of Callistemon citrinus against the oxidative stress during a hypercaloric diet in rats

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidade+1
  42. 2022

    Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review

    FavorávelMetanáliseDorCâncerDor — Crônica+2
  43. 2022

    Safety and efficacy of a digital therapeutic for substance use disorder: Secondary analysis of data from a NIDA clinical trials network study

  44. 2022

    Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDoenças de PelePrurido
  45. 2022

    Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

  46. 2022

    Safety of Bifidobacterium breve, Bif195, employing a human exercise-induced intestinal permeability model: a randomised, double-blinded, placebo-controlled, parallel group trial

    InconclusivoEnsaio Clínico Duplo-CegoInflamaçãoProteína Ligadora de Ácidos Graxos (FABP)Exercício Físico
  47. 2022

    Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants

    FavorávelEnsaio Clínico Duplo-CegoTetraidrocanabinol (THC)THC Farmacêutico
  48. 2022

    Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants

  49. 2022

    Saturated Fatty Acid Intake Is Associated with Total Mortality in a Nationwide Cohort Study

  50. 2022

    Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations

  51. 2022

    Self-Reported Cannabis Use Is Associated With a Lower Rate of Persistent Opioid Use After Total Joint Arthroplasty

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+2
  52. 2022

    Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial

    DesfavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisAnsiedadeDisfunção Cognitiva+1
  53. 2022

    Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste

    InconclusivoEstudo em AnimaisDorCâncerAnsiedadeTetraidrocanabinol (THC)Ácido Canabidiólico (CBD-a)+4
  54. 2022

    Serum Individual Nonesterified Fatty Acids and Risk of Heart Failure in Older Adults

  55. 2022

    Serum Metabolomic Analysis of Male Patients with Cannabis or Amphetamine Use Disorder

  56. 2022

    Severe liver dysfunction in a toddler receiving nonprescription phytocannabinoid

    DesfavorávelMetanáliseEfeitos Adversos da CannabisInsuficiência Hepática
  57. 2022

    Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials

    InconclusivoMetanálise ClínicaEfeitos Adversos da Cannabis
  58. 2022

    Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome

  59. 2022

    Sex differences in medical cannabis-related adverse effects

  60. 2022

    Sex differences in the acute effects of intravenous (IV) delta-9 tetrahydrocannabinol (THC)

    InconclusivoEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisTetraidrocanabinol (THC)
  61. 2022

    Sex Differences in the Association Between Cannabis Use and Diabetes Mellitus among U.S. Adults: The National Health and Nutritional Examination Survey, 2013-2018

    FavorávelMetanáliseDiabetes
  62. 2022

    Sexually Transmitted Infection Testing After Brief Intervention for Risk Behaviors in School-Based Health Centers

  63. 2022

    Shifting the Paradigm on Cannabis Safety

    DesfavorávelMetanáliseCâncerInflamaçãoEfeitos Adversos da CannabisCBD Farmacêutico+17
  64. 2022

    Short term feeding of industrial hemp with a high cannabidiolic acid (CBDA) content increases lying behavior and reduces biomarkers of stress and inflammation in Holstein steers

    FavorávelEnsaio Clínico VeterinárioInflamaçãoAplicações VeterináriasÁcido Canabidiólico (CBD-a)
  65. 2022

    Short-Term Very High Carbohydrate Diet and Gut-Training Have Minor Effects on Gastrointestinal Status and Performance in Highly Trained Endurance Athletes

    InconclusivoEnsaio ClínicoSíndrome MetabólicaProteína Ligadora de Ácidos Graxos (FABP)
  66. 2022

    Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways

  67. 2022

    Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network

  68. 2022

    Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation

  69. 2022

    Sleep time differs among people who co-use cocaine and cannabis compared to people who only use cocaine

  70. 2022

    Societal Costs and Outcomes of Medical and Recreational Marijuana Policies in the United States: A Systematic Review

  71. 2022

    Spinal cannabinoid CB1 or CB2 receptors activation attenuates mechanical allodynia in streptozotocin-induced diabetic rats

  72. 2022

    Spiritual Benefit from Cannabis

    FavorávelMetanáliseMedicina Mente-Corpo
  73. 2022

    Spirulina phycocyanin extract and its active components suppress epithelial-mesenchymal transition process in endometrial cancer via targeting TGF-beta1/SMAD4 signaling pathway

    FavorávelEstudo em AnimaisCâncerCâncer — ÚteroFicocianina
  74. 2022

    Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts

    DesfavorávelEstudo LaboratorialInflamação
  75. 2022

    Status and Impacts of Recreational and Medicinal Cannabis Policies in Africa: A Systematic Review and Thematic Analysis of Published and "Gray" Literature

    InconclusivoMetanáliseEfeitos Adversos da Cannabis
  76. 2022

    Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice

  77. 2022

    Substance Use Among Youth During the COVID-19 Pandemic: a Systematic Review

  78. 2022

    Substance Use Screening, Brief Intervention, and Referral to Treatment in Pediatric Primary Care, School-Based Health Clinics, and Mental Health Clinics

    DesfavorávelMetanáliseDependência QuímicaDependência — Cannabis
  79. 2022

    Substance-induced psychosis and cognitive functioning: A systematic review

    DesfavorávelMetanáliseDependência QuímicaDisfunção CognitivaPsicose+1
  80. 2022

    Succinylcholine Induced Rhabdomyolysis in a Heavy Marijuana Smoker: A Case Report

    DesfavorávelMetanáliseInsuficiência Renal
  81. 2022

    Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  82. 2022

    Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report

    DesfavorávelMetanáliseDoenças Cardiovasculares (DCV)EpilepsiaPsicoseAyahuasca+7
  83. 2022

    Synergistic effects of carvacrol, α-terpinene, γ-terpinene, ρ-cymene and linalool against Gardnerella species

    FavorávelEstudo LaboratorialInfecções Bacterianas
  84. 2022

    Synthetic cannabinoid CP-55,940 induces apoptosis in a human skeletal muscle model via regulation of CB1 receptors and L-type Ca2+ channels

    FavorávelEstudo LaboratorialCâncerCâncer — Tecidos MolesCanabinoides Sintéticos CP-x
  85. 2022

    Synthetic cannabinoids and ST elevation myocardial infarction

  86. 2022

    Synthetic Strategies for Rare Cannabinoids Derived from Cannabis sativa

    InconclusivoEstudo LaboratorialCanabigerol (CBG)Canabicromeno (CBC)+2
  87. 2022

    Systematic literature review of human studies assessing the efficacy of cannabidiol for social anxiety

    FavorávelMetanáliseAnsiedadeEndocanabinoide (não especificado)
  88. 2022

    Systematic Review on Transdermal/Topical Cannabidiol Trials: A Reconsidered Way Forward

    InconclusivoMetanáliseDorTranstornos de ComportamentoDoenças de Pele
  89. 2022

    Systematic reviews of randomized controlled trials of cannabinoid products in chronic pain conditions and for symptoms associated with multiple sclerosis: what do they tell us?

    InconclusivoMetanálise ClínicaDorDor — CrônicaEsclerose Múltipla+2
  90. 2022

    Targeting cannabinoid receptor 2 (CB2) limits collagen production-An in vitro study in a primary culture of human fibroblasts

  91. 2022

    Targeting maladaptive reactivity to negative affect in emerging adults with cannabis use disorder: A preliminary test and proof of concept

    FavorávelEnsaio ClínicoDependência QuímicaDependência — Cannabis
  92. 2022

    Targeting the Achilles’ Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide

    FavorávelEstudo LaboratorialInfecções BacterianasAnandamida (AEA)
  93. 2022

    Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome

  94. 2022

    Targeting the Endocannabinoid System in the Treatment of Posttraumatic Stress Disorder: A Promising Case of Preclinical-Clinical Translation?

  95. 2022

    Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer?

  96. 2022

    Targeting the Endocannabinoidome in Pancreatic Cancer

  97. 2022

    Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review

  98. 2022

    Terpene-Enriched CBD oil for treating autism-derived symptoms unresponsive to pure CBD: Case report

  99. 2022

    Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives

  100. 2022

    Tetrahydrocannabinol fails to reduce hair pulling or skin picking: results of a double-blind, placebo-controlled study of dronabinol

    InconclusivoEnsaio Clínico Duplo-CegoTricotilomaniaTHC Farmacêutico